Astoria Portfolio Advisors LLC. Has $1.03 Million Stock Position in The Procter & Gamble Company (NYSE:PG)

Astoria Portfolio Advisors LLC. increased its position in shares of The Procter & Gamble Company (NYSE:PG) by 3.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,610 shares of the company’s stock after buying an additional 230 shares during the quarter. Astoria Portfolio Advisors LLC.’s holdings in Procter & Gamble were worth $1,028,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Advantage Trust Co acquired a new position in Procter & Gamble during the 4th quarter worth approximately $28,000. Wyrmwood Management LLC acquired a new position in Procter & Gamble during the 4th quarter worth approximately $29,000. Naples Money Management LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter worth approximately $29,000. Transcendent Capital Group LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter worth approximately $31,000. Finally, Criterion Capital Advisors LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter worth approximately $33,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $164.92 on Friday. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $169.41. The stock has a fifty day simple moving average of $165.60 and a two-hundred day simple moving average of $158.81. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The firm has a market cap of $389.23 billion, a price-to-earnings ratio of 26.95, a price-to-earnings-growth ratio of 3.35 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same period last year, the company earned $1.37 earnings per share. The business’s revenue for the quarter was up .6% on a year-over-year basis. Analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date of this dividend was Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Transactions at Procter & Gamble

In other news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the transaction, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Moses Victor Javier Aguilar sold 9,149 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $167.72, for a total value of $1,534,470.28. Following the sale, the insider now owns 12,929 shares in the company, valued at $2,168,451.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sundar G. Raman sold 31,924 shares of the stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the sale, the chief executive officer now owns 19,042 shares in the company, valued at approximately $3,179,061.90. The disclosure for this sale can be found here. Insiders sold 154,544 shares of company stock valued at $25,413,051 over the last three months. Company insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on PG. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and increased their price objective for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. Barclays increased their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Argus increased their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. BNP Paribas assumed coverage on Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective for the company. Finally, StockNews.com raised Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Tuesday, June 25th. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $170.72.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.